Malden, MA, United States of America

Xi Ren

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: The General Hospital Corporation. Active years: 2020-2025.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Xi Ren

Introduction

Xi Ren is an accomplished inventor based in Malden, MA (US), known for her significant contributions to the field of biological materials and tissue engineering. With a total of 2 patents to her name, she has made strides in developing methods that enhance the functionality of biological materials.

Latest Patents

One of Xi Ren's latest patents focuses on "Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions." This application provides innovative methods for functionalizing organs or tissues of mammals by administering specific nutrients, such as peracetylated N-azido galactosamine (Ac4GalNAz). The patent also details methods for selectively functionalizing the extracellular matrix (ECM) of organs or tissues, leading to the creation of decellularized scaffolds that are reactive in bioorthogonal chemical reactions. Additionally, her work includes the development of biological prosthetic mesh and mammalian organs and tissues for transplantation.

Another notable patent by Xi Ren is titled "Regeneration of a functional pulmonary vascular bed." This method involves delivering endothelial and perivascular cells to a lung scaffold, along with a multiphase culture program that includes both angiogenic and stabilization mediums. This innovative approach aims to enhance vascular regeneration in lung tissues.

Career Highlights

Xi Ren is currently employed at The General Hospital Corporation, where she continues to push the boundaries of research in biological engineering

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…